Using Visual Thinking Strategies to Support Development of Pharmacy Student Competency in Person-Centered Care.

Objective. To evaluate the introduction of 10 Visual Thinking Strategies (VTS) sessions into year 2 of a Bachelor of Pharmacy (BPharm) program with the aim of assisting students in developing the skills and attitudes required for inclusive practice.Methods. The evaluation used a cross-sectional study design. All members of the first two successive student cohorts to complete multiple VTS sessions completed a 38-item online reflective questionnaire exploring student perceptions of competency development, transference, and session acceptability. Students were asked for their consent to include their responses in a research study. Closed-question responses were analyzed to produce descriptive statistics. Free-text responses were categorized and quantified using an inductive approach and manifest content analysis.Results. Fifty-six percent of the students (98 of 174) allowed their responses to be included in the study. Students generally believed the sessions had supported their development of person-centred communication, cultural competence, and critical thinking skills. The minimum level of agreement that improvement in an area occurred was 74.5%. Free-text responses revealed the perception of additional skill and attitude development. Sixty percent of participants had thought about the VTS questions or used what they had learned in the VTS sessions in other settings. Eighty-six percent of students agreed that content on VTS should remain in the BPharm curriculum.Conclusion. Incorporating regular VTS sessions into the second year of a BPharm program was acceptable to students. Data suggest that inclusion of multiple VTS sessions is a valuable addition to the pharmacy curriculum, offering affective learning experiences which support development and transference of key skills and attitudes relating to the provision of inclusive person-centred care.

Identifying compliance issues with prescription medicines among older people: a pilot study.

BACKGROUND: Older people are at greater risk from polypharmacy and adverse effects due to interactions and altered pharmacokinetics. They may also have greater difficulty managing their medicines and complying with dosage regimens for various reasons. OBJECTIVE: To identify the types of medicine compliance issues that occur among older people. METHOD: The study was undertaken in suburbs of the city of Auckland, New Zealand. A sample of 31 older people (> or = 65 years of age) living in the community consented to participate in the study. Semi-structured interviews and observation were used to determine how older people were managing their medicines. Observation of the interaction between the pharmacist and older person was performed to gather baseline information and semi-structured interviews were undertaken within 1 month to determine how older people were using their medicines and to identify compliance issues surrounding their use of medicines. Observation of the pharmacist-older person interaction was undertaken in the pharmacy where the older people usually collected their medicines, and participants were subsequently interviewed in their homes. The main outcome measure was compliance issues associated with the use of medicines. RESULTS: The main issues identified were alteration of labelled medicine instructions; transferring medicine into other containers and the associated labelling and safety issues; and patients not taking medicines for various reasons, including swallowing difficulties, expense, difficulty in opening packaging, confusion about the regimen and adverse effects experienced and personal reasons. There was an average of five compliance issues per participant. CONCLUSION: This study identified intentional and non-intentional compliance issues that could hinder the optimal use of medicines by older people who are at greater risk of medicine-related adverse effects. Large quantities of medicines, confusion, and lack of knowledge as to why a medicine had been prescribed contributed to non-compliance. Appropriate communication between the pharmacist and patient, patient education and aids such as medication cards and referral for medication review could improve compliance in this age group.

Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.

OBJECTIVE: To explore pharmacist's views on the shift in ethos, funding and service delivery model introduced through the New Zealand's Community Pharmacy Services Agreement (CPSA). METHODS: A purposive sampling approach drew pharmacists from a matrix who were then contacted via telephone and invited to be interviewed. Semistructured interviews were conducted face-to-face with community pharmacists (n = 17) across urban and rural New Zealand. An interview schedule exploring 12 subject areas was used to facilitate discussion and determine pharmacist's views and understanding of the CPSA. The interviews were recorded and transcribed verbatim and a general inductive approach was taken to identifying emergent themes. KEY FINDINGS: Key themes that emerged were: pharmacists supported the philosophy behind the CPSA, pharmacists understanding of the CPSA, implementing CPSA-related services, perceived impact on patient outcomes and future sustainability of the CPSA. Overall, pharmacists supported the alignment of funding with patient-centred services, but pharmacy owners reported difficulty understanding the funding model, resulting in uncertainty over income. Several pharmacists believed the quality of care offered had not changed, while others found their attitudes towards care had evolved. All pharmacists communicated an increase in their workload and many perceived the sustainability of the CPSA to be linked to its ability to financially sustain community pharmacies. CONCLUSIONS: The majority of pharmacists believed in the philosophy of the CPSA, but expressed concerns over funding, workload and benefits for patients. Future research is required to determine generalisability of these findings, investigate patient perspectives and assess the effect of the CPSA on patient outcomes.

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand.

OBJECTIVE: The objective of this study was to evaluate general practitioners' (GPs) perceptions regarding access to medicines in New Zealand. DESIGN: Qualitative. SETTING: Primary care. PARTICIPANTS: GPs. MAIN OUTCOME MEASURES: GPs' views and perceptions. RESULTS: GPs were of the view that the current range of medicines available in New Zealand was reasonable; however, it was acknowledged that there were some drugs that patients were missing out on. When considering the range of subsidised medicines available in New Zealand, some GPs felt that there had been an improvement over recent years. It was highlighted that unexpected funding changes could create financial barriers for some patients and that administrative procedures and other complexities created barriers in receiving a subsidy for restricted medicines. GPs also reported problems with the availability and sole supply of certain medicines and claimed that switching from a branded medicine to its generic counterpart could be disruptive for patients. CONCLUSIONS: The research concluded that although there were some issues with the availability of certain drugs, most GPs were satisfied with the broader access to medicines situation in New Zealand. This view is to contrary to the situation presented by the pharmaceutical industry. The issues around sole supply, the use of generic medicines and the administrative barriers regarding funding of medicines could be improved with better systems. The current work provides a solid account of what GPs see as the advantages and disadvantages of the current system and how they balance these demands in practice.